ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Nym Named Among Top 100 Healthcare Technology Companies by The Healthcare Technology Report

By: via Business Wire

Award Recognizes Nym’s Leadership in Autonomous Medical Coding and Innovative Solution for Revenue Cycle Management

Nym, a leader in autonomous medical coding, today announced that it has been named to The Healthcare Technology Report’s Top 100 Healthcare Technology Companies of 2024. This recognition underscores Nym’s role in automating and optimizing revenue cycle management for providers as they face increasing administrative complexity, workforce shortages, and additional resource constraints.

The leading online resource for investors, executives, and professionals in the healthcare technology industry, The Healthcare Technology Report is renowned for its in-depth reports and insights on companies that are driving innovation and growth in the sector. The Top 100 Healthcare Technology Companies list celebrates organizations that stand out for their technological breakthroughs, customer impact, and ability to reshape healthcare delivery.

“We’re honored to be recognized alongside such an impressive list of innovative companies as we further our mission of empowering providers with AI-based solutions that reduce administrative burdens and optimize revenue cycle management,” said Or Peles, Nym’s CEO. “This recognition is a testament to the transformative potential of autonomous medical coding, the remarkable work of our team, and the strong partnerships we have built with clients across the US.”

Powered by innovative Clinical Language Understanding (CLU) technology, Nym’s autonomous medical coding engine accurately translates provider notes within patient charts into medical codes in seconds and with no human intervention. With capabilities for emergency medicine, radiology, outpatient surgery, outpatient visits, inpatient professional services, and urgent care, Nym is helping leading healthcare providers improve operational efficiency, optimize financial performance, and reduce administrative burdens, ultimately enabling providers to focus more time on patient care.

For more information about The Healthcare Technology Report’s Top 100 Healthcare Technology Companies of 2024, including the full list of awardees, visit The Healthcare Technology Report website.

About Nym

Nym is a leader in transforming clinical language into actionable information, which can remove inefficiencies that add billions to the cost of care. By combining cutting-edge technology with clinical expertise and a deep understanding of medical language, Nym is able to accurately decode medical charts in a way that is efficient, explainable, and compliant. The Company’s innovative solution for revenue cycle management (RCM) takes provider notes within patient charts and translates them into accurate diagnostic and billing charge codes, all within a matter of seconds and with zero human intervention. Along with over 95% accuracy of improved coding, Nym’s RCM solution delivers audit-ready, traceable documentation for every code it generates, ensuring total visibility into why each code was assigned. The Nym solution can be deployed and scaled based on volume and workflow needs, easing administrative burdens and allowing clinical teams to spend more time focused on patient care.

Based in New York City with R&D capabilities in Tel Aviv, Nym is building an interdisciplinary team of specialists including technologists, physicians, mathematicians, computational linguists, engineers, medical coders and more. Investors in Nym include PSG, Addition, GV, Bessemer Venture Partners, Dynamic Loop Capital, Tiger Global, Zach Weinberg and Nat Turner. To learn more about Nym, visit nym.health.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.